
|Articles|February 5, 2008
New label approved to reflect Thrombin-JMI manufacturing changes
FDA approves revised labeling for Thrombin-JMI.
Advertisement
Enhanced processes to reduce Factor V light chain content to undetectable levels during the manufacture of
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
2
Vaccine Policy in Flux: Stories Pharmacists Need to Follow
3
ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain
4
Pharmacists Are Essential Drivers of Opioid Stewardship Programs
5






























